Breathtaking Insights into the Unmet Needs of Rare Lung Diseases - European Medical Journal

Breathtaking Insights into the Unmet Needs of Rare Lung Diseases

Respiratory

Listen to our latest podcast on rare lung diseases, recapping an insightful symposium from the European Respiratory Society (ERS) International Congress 2023. We are joined by the following renowned experts:

Marlies Wijsenbeek, Erasmus Medical Centre, Rotterdam, the Netherlands

Gerry McElvaney, Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences, Dublin, Ireland

Luca Richeldi, Agostino Gemelli Hospital and Catholic University of the Sacred Heart, Rome, Italy

In a roundtable discussion, expert guests will be delivering the medical recommendations on the unmet needs in the field, as discussed at congress. Topics covered will offer insights into idiopathic pulmonary fibrosis, alpha-1 antitrypsin deficiency, and diagnostic delay associated with idiopathic pulmonary fibrosis.

Predicting the disease course and prognosis in IPF

The EMJ Podcast | Bonus Episode

In this section, the panel considers the expert insights of Prof. Wijsenbeek, concerning the challenges of predicting the disease course and prognosis of patients with idiopathic pulmonary fibrosis (IPF). The conversation reflects on current knowledge, real-world practices, treatment options, and tools available to healthcare professionals.

Spotify | Apple | Amazon MusicDownload MP3 (12:33 mins)

Diagnostic reach for AATD

The EMJ Podcast | Bonus Episode

In this section, which is directed towards the expertise of Prof. McElvaney, the discussion focuses specifically on the relevance of detecting and diagnosing Alpha 1 Antitrypsin Deficiency (AATD) for lung diseases, as well as consideration of other diagnostic techniques and standards of care options for patients with AATD.

Spotify | Apple | Amazon MusicDownload MP3 (11:25 mins)

Diagnostic delay in IPF

The EMJ Podcast | Bonus Episode

In this section, the panel considers the diagnostic tools and approaches available for healthcare professionals to use for suspected idiopathic pulmonary fibrosis (IPF). The discussion is directed towards the expertise of Prof. Luca Richeldi, who emphasises the importance of knowledge, education, and medical examination approaches for addressing the unmet medical needs associated with the awareness of, and diagnostic delays of IPF.

Spotify | Apple | Amazon MusicDownload MP3 (12:01 mins)

For further insights, read our article ‘Shaping the Future in Rare Lung Diseases: From Imaging to Patient Management – European Medical Journal (emjreviews.com)‘ now!

The publication of this podcast was funded by CSL Behring. The views and opinions expressed are exclusively those of the speakers.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>